To determine if the expression of BMI1 protein is restricted to CSCs, we isolated CD133+ cells, the most commonly used marker to isolate GBM stem cells despite ongoing controversies [3,51-55], from GBM xenograft tumors and compared their BMI1 protein expression with CD133− tumor cells. This evidence concerns the gene BMI1 and glioblastoma.